Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Yilmaz, Omer

Massachusetts Institute Of Technology
United States

PROSPECT - Stem cell models 1OT2CA297570-01 Asad Umar, D.V.M., Ph.D.
Yost, Kathleen J

Spectrum Health Hospitals
United States

Cancer Research Consortium of West Michigan (CRCWM) 5UG1CA189860-11 Vanessa A. White, M.P.H.
You, Ming

Methodist Hospital Research Institute
United States

Chemoprevention of lung cancer by targeting lonidamine to mitochondria 5R01CA232433-05 John Clifford, Ph.D.
You, Ming

Methodist Hospital Research Institute
United States

Inhibition of Oral Tumorigenesis by Antitumor B 7R01CA205633-06 Eva Szabo, M.D.
You, Ming

Methodist Hospital Research Institute
United States

Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis 1R01CA280746-01A1 John Clifford, Ph.D.
Young, Steven L

Duke University
United States

Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis 5P01HD106485-04 Goli Samimi, Ph.D., M.P.H.
Yu, Dihua

University Of Tx Md Anderson Can Ctr
United States

Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer 5R01CA270010-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.
Yu, Danxia

Vanderbilt University Medical Center
United States

Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery 5R01CA275864-02 Edward Sauter, M.D., Ph.D.
Yu, Anthony Francis

Sloan-Kettering Inst Can Research
United States

Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial 5R37CA273923-02 PAR-21-329 (R01 Clinical Trial Optional) Eileen Dimond, R.N., M.S.
Yu, Anthony Francis

Sloan-Kettering Inst Can Research
United States

Effects of Exercise on Changes in Cardiovascular Biomarkers in Patients with Breast Cancer During Anthracycline-based Chemotherapy 5R03CA277194-02 Eileen Dimond, R.N., M.S.